Scientific Meeting: Implications of AI and Super-Intelligence for Psychoanalysis
-
March 10, 2026
8:00 pm - 10:00 pm
***This meeting is virtual and will be held on ZOOM.***
NYPSI’s 1083rd Scientific Meeting:
“Implications of AI and Super-Intelligence for Psychoanalysis”
Tuesday, March 10, 2026
8:00 – 10:00 PM (EST)
Presenter: Andrew Rosendahl, M.D., Ph.D.
Discussant: Andrew Gerber, M.D., Ph.D.
This presentation is designed for psychoanalysts and psychoanalytic candidates seeking to understand the rapidly evolving landscape of artificial intelligence and its implications for clinical practice and psychoanalysis. Drawing on both technical knowledge and psychoanalytic theory, the presenter—a member psychoanalyst with a science and technology background—will examine how AI is already appearing in our consulting rooms, how it may function as a new object of transference and resistance, and what it means for the future of our field. Through didactic presentation, vignettes, and guided discussion, participants will be invited to approach AI as psychoanalysts—with curiosity, openness, and the capacity to sit with something that doesn’t yet fit our existing categories.
2 Contact Hours. 2 CME/CE credits will be offered. See details below.
General Admission: $50
Student Admission: $35
Free Admission for current NYPSI members/students and HFI Candidates
Please note registration closes at 5 PM on Monday, December 8th.
THIS MEETING IS VIRTUAL; READ INSTRUCTIONS BELOW:
***Registration in Zoom Before the Meeting is Required to Attend***
After you have completed registering for the event, please look out for a confirmation email with more details on how to receive your Zoom Link.
Evaluation Survey and CME/CE documentation will be emailed after the event.
Please make sure you type your email correctly when you register! Contact with questions.
-
- Rabeyron, T. (2025). Artificial intelligence and psychoanalysis: Is it time for psychoanalyst.AI? Frontiers in Psychiatry, 16, 1558513. https://doi.org/10.3389/fpsyt.2025.1558513
- Fiske, A., Henningsen, P., & Buyx, A. (2021). “Like I’m talking to a real person”: Exploring the meaning of transference for the use and design of AI-based applications in psychotherapy. Frontiers in Psychology, 12, 720476. https://doi.org/10.3389/fpsyg.2021.720476
- Hadar-Shoval, D., Alon-Tirosh, M., Morag, O., Elyoseph, Z. (2024). The artificial third: A broad view of the effects of introducing generative artificial intelligence on psychotherapy. JMIR Mental Health, 11, e54781. https://doi.org/10.2196/54781
Andrew Rosendahl, M.D., Ph.D. is a psychiatrist and psychoanalyst practicing in New York City. He earned his M.D. and Ph.D. in neuroscience from the University of Miami and completed his psychoanalytic training at the New York Psychoanalytic Society & Institute (NYPSI). As a faculty member at NYPSI, Dr. Rosendahl teaches a neuropsychoanalysis course designed to bridge the gap between neuroscience and psychoanalytic knowledge. Additionally, he is a devoted technophile and the co-founder of a healthcare tech startup. His enthusiasm for technology includes a keen interest in large language models and artificial intelligence, and their potential to shed light on the workings of the human mind.
Andrew J. Gerber, M.D., Ph.D. is the President and Medical Director of Silver Hill Hospital, a private non-profit psychiatric hospital in New Canaan, Connecticut. Dr. Gerber serves as associate clinical professor at the Yale University Child Study Center and as a board member of the William Alanson White Institute of Psychiatry, Psychoanalysis, and Psychology. Prior to joining Silver Hill, Dr. Gerber was Medical Director and CEO of the Austen Riggs Center in Stockbridge, Massachusetts. He is also the former co-director of the Sackler Parent-Infant Program at Columbia University, former director of the MRI Research Program at the New York State Psychiatric Institute and former director of research at the Columbia University Center for Psychoanalytic Training and Research.
CONTINUING EDUCATION
Educational Objectives: Upon completion of this activity, participants should be able to:
- Analyze and apply psychoanalytic thinking to the emergence of artificial intelligence and AI-based bots—considering how they may participate in the compromise formation of clinical material and function as objects of transference, resistance, competition, and as potential sources of genuine therapeutic assistance—and use this understanding to formulate analytic responses in treatment.
- Discuss the multiple layers and scales of AI’s implications for psychoanalytic practice, including its potential impact on insurance reimbursement, accessibility of mental health care, and the evolving role of human therapists as AI-based interventions become increasingly prevalent.
Psychologists
New York Psychoanalytic Society & Institute is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY – 0073.
New York Psychoanalytic Society & Institute is approved by the American Psychological Association (APA) to sponsor continuing education programs for psychologists. New York Psychoanalytic Society & Institute maintains responsibility for this program and its content. DISCLOSURE: None of the planners and presenters of this CE program has any relevant financial relationships to disclose.
Social Workers
New York Psychoanalytic Society & Institute is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW – 0317.